NCT00179517 Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo Status COMPLETED Phase PHASE2
NCT00177242 Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic Carcinoma Status COMPLETED Phase PHASE2
NCT00176332 Impact of Rosuvastatin on Endothelial Function and Inflammation in Patients With Chronic Heart Failure Status COMPLETED Phase PHASE2
NCT00170001 Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy Status COMPLETED Phase NA
NCT00169871 Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia Status COMPLETED Phase N/A
NCT00169221 Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas Status TERMINATED Phase PHASE2
NCT00166400 A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation. Status COMPLETED Phase PHASE4
NCT00165308 Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors Status COMPLETED Phase NA
NCT00163527 Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013) Status COMPLETED Phase PHASE3
NCT00163514 Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403) Status COMPLETED Phase PHASE3
NCT00163501 Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404) Status COMPLETED Phase PHASE3
NCT00163488 Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409) Status COMPLETED Phase PHASE3
NCT00163475 Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015) Status COMPLETED Phase PHASE3
NCT00163462 Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206) Status COMPLETED Phase PHASE3
NCT00163449 Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207) Status COMPLETED Phase PHASE3
NCT00163436 Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145) Status COMPLETED Phase PHASE3
NCT00163423 Efficacy of Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (12 to 75 y) (BY9010/M1-142) Status COMPLETED Phase PHASE3
NCT00163410 Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205) Status COMPLETED Phase PHASE3
NCT00163397 Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137) Status COMPLETED Phase PHASE3